Sen­ate Fi­nance Com­mit­tee plots ways to tweak Medicare to re­duce ster­ile in­jectable short­ages

The top De­mo­c­rat and Re­pub­li­can in the Sen­ate Fi­nance Com­mit­tee out­lined ways in which new leg­is­la­tion could help com­bat decades­long short­ages of cheap, gener­ic ster­ile in­jecta­bles and oth­er es­sen­tial med­i­cines.

Specif­i­cal­ly, a co-au­thored white pa­per, pub­lished Thurs­day, pledges to cre­ate a new pay­ment bench­mark for gener­ic ster­ile in­jecta­bles, in­clud­ing po­ten­tial “lump-sum pay­ments or oth­er mech­a­nisms” for those help­ing to pre­vent and mit­i­gate short­ages. But the com­mit­tee is grap­pling with how cer­tain de­sign fea­tures of the new bench­mark for gener­ic in­jecta­bles will look, in­clud­ing how it “would avoid ex­ac­er­bat­ing race to-the-bot­tom pric­ing” while pro­mot­ing com­pe­ti­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER